Market Overview

Dixie Brands and Khiron Life Sciences Mutually Agree to Terminate Joint Venture

Share:

DENVER, March 20, 2020 /CNW/ - Today, Dixie Brands Inc. ("Dixie" or "the Company") ((DIXI), (OTCQX:DXBRF), (Frankfurt: 0QV), one of the cannabis industry's leading consumer packaged goods ("CPG") companies, confirmed that in light of the contemplated change of control in connection with Dixie's pending transaction with BR Brands, Dixie and Khiron Life Sciences Corp. have mutually agreed to terminate the joint venture that was announced on January 30, 2019.

ABOUT DIXIE BRANDS, INC

Dixie Brands Inc. is leading the CPG cannabis industry by championing freedom of choice for consumers around the world. Through its licensed partners, Dixie has been perfecting the art and science of creating award-winning THC and CBD-infused products for nearly a decade. A true multi-state operator currently in California, Colorado, Maryland, Michigan, Nevada and Oklahoma. Dixie's relentless commitment to product innovation from fun to functional has earned the brand a place as one of the industry's most recognized consumer brands.  Dixie's portfolio features over 100 products across more than 15 different product categories representing the industry's finest edibles, beverages, tinctures, topicals and connoisseur grade extractions, as well as world-class CBD-infused wellness products and pet supplements. To find out more about Dixie's innovative products, visit www.dixiebrands.com

SOURCE Dixie Brands, Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2020/20/c5785.html

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com